Patient life style with anti-coagulation treatment: first results of the pilot study
Open Access
- 1 July 2020
- journal article
- Published by Palacky University Olomouc in Profese online
- Vol. 13 (1), 46-55
- https://doi.org/10.5507/pol.2020.010
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Epidemiological study of new oral anticoagulantsKlinická farmakologie a farmacie, 2018
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of CardiologyCor et Vasa, 2016
- Antithrombotic Therapy for VTE DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2016
- Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trialAge and Ageing, 2015
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2015
- Profile of CZECH AF 2012. Profile of atrial fibrillation patients receiving antithrombotic therapyCor et Vasa, 2014
- Summary of the European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): Prepared by the Czech Society of CardiologyCor et Vasa, 2014
- Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFEuropean Heart Journal, 2013
- Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF TrialJournal of Invasive Cardiology, 2013
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011